Beta Bionics Inc

BBNXNASDAQ · USD
22.19USD0.00 (-2.72%)
3510

Beta Bionics Inc (BBNX) Options Open Interest

BBNX options open interest is 2,296 contracts. The 2-week average daily volume is 63 contracts across the chain.

Read more

Monitoring BBNX open interest helps you see where real money is positioned on Beta Bionics Inc's options and which strikes are attracting the most commitment from traders. Beta Bionics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor BBNX options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising BBNX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Beta Bionics Inc to settle.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.

It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where BBNX open interest is concentrated. Our scanner maps Beta Bionics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Beta Bionics Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
10.0010.8015.1012.95186%+0.9763341
15.006.4010.108.25142%+0.9105212
12.508.4012.6010.50151%+0.9613126
7.5013.3017.6015.45247%+0.981656
22.501.604.703.15129%+0.584834
Puts
5.002.602.60896%-0.0353120
7.502.652.65646%-0.0668116
17.500.800.80132%-0.16713
10.003.203.20552%-0.09831
15.003.403.40361%-0.17921

As of September 23, 2026

Follow the money

Track BBNX open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial